Format
Items per page
Sort by

Send to:

Choose Destination

Search results

Items: 1 to 20 of 615

1.

The acceptability and cost of a home-based chlamydia retesting strategy: findings from the REACT randomised controlled trial.

Smith KS, Kaldor JM, Hocking JS, Jamil MS, McNulty AM, Read P, Bradshaw CS, Chen MY, Fairley CK, Wand H, Worthington K, Blake S, Knight V, Rawlinson W, Saville M, Tabrizi SN, Garland SM, Donovan B, Guy R.

BMC Public Health. 2016 Jan 28;16(1):83. doi: 10.1186/s12889-016-2727-4.

2.

"I Do Feel Like a Scientist at Times": A Qualitative Study of the Acceptability of Molecular Point-Of-Care Testing for Chlamydia and Gonorrhoea to Primary Care Professionals in a Remote High STI Burden Setting.

Natoli L, Guy RJ, Shephard M, Causer L, Badman SG, Hengel B, Tangey A, Ward J, Coburn T, Anderson D, Kaldor J, Maher L; TTANGO Investigators.

PLoS One. 2015 Dec 29;10(12):e0145993. doi: 10.1371/journal.pone.0145993. eCollection 2015.

3.

Development of immunity following financial incentives for hepatitis B vaccination among people who inject drugs: A randomized controlled trial.

Day CA, Shanahan M, Wand H, Topp L, Haber PS, Rodgers C, Deacon R, Walsh N, Kaldor J, van Beek I, Maher L; Hepatitis Acceptability Group Vaccine Incentives Trial (HAVIT) Study Group.

J Clin Virol. 2016 Jan;74:66-72. doi: 10.1016/j.jcv.2015.11.031. Epub 2015 Dec 2.

PMID:
26679830
4.

Community and clinic-based screening for curable sexually transmissible infections in a high prevalence setting in Australia: a retrospective longitudinal analysis of clinical service data from 2006 to 2009.

Silver B, Kaldor JM, Rumbold A, Ward J, Smith K, Dyda A, Ryder N, Yip TW, Su JY, Guy RJ.

Sex Health. 2015 Dec 18. doi: 10.1071/SH15077. [Epub ahead of print]

PMID:
26678863
5.

Rationale and design of FORTH: a randomised controlled trial assessing the effectiveness of HIV self-testing in increasing HIV testing frequency among gay and bisexual men.

Jamil MS, Prestage G, Fairley CK, Smith KS, Kaldor JM, Grulich AE, McNulty AM, Chen M, Holt M, Conway DP, Wand H, Keen P, Batrouney C, Bradley J, Bavinton BR, Ryan D, Russell D, Guy RJ.

BMC Infect Dis. 2015 Dec 10;15(1):561. doi: 10.1186/s12879-015-1300-6.

6.

Mass Drug Administration for Scabies Control in a Population with Endemic Disease.

Romani L, Whitfeld MJ, Koroivueta J, Kama M, Wand H, Tikoduadua L, Tuicakau M, Koroi A, Andrews R, Kaldor JM, Steer AC.

N Engl J Med. 2015 Dec 10;373(24):2305-13. doi: 10.1056/NEJMoa1500987.

7.

Medicare Benefits Schedule data to monitor influenza immunisation in Australian adults.

Dyda A, MacIntyre CR, Banks E, Kaldor J, Newall AT, McIntyre P, Liu B.

Public Health Res Pract. 2015 Sep 30;25(4). pii: phrp2541543. doi: 10.17061/phrp2541543.

8.

Incidence and predictors of annual chlamydia testing among 15-29 year olds attending Aboriginal primary health care services in New South Wales, Australia.

Graham S, Guy RJ, Ward JS, Kaldor J, Donovan B, Knox J, McCowen D, Bullen P, Booker J, O'Brien C, Garrett K, Wand HC.

BMC Health Serv Res. 2015 Sep 30;15:437. doi: 10.1186/s12913-015-1116-5.

9.

HIV transmission law in the age of treatment-as-prevention.

Haire B, Kaldor J.

J Med Ethics. 2015 Dec;41(12):982-6. doi: 10.1136/medethics-2014-102122. Epub 2015 Sep 29.

PMID:
26420071
10.

HPV.edu study protocol: a cluster randomised controlled evaluation of education, decisional support and logistical strategies in school-based human papillomavirus (HPV) vaccination of adolescents.

Skinner SR, Davies C, Cooper S, Stoney T, Marshall H, Jones J, Collins J, Hutton H, Parrella A, Zimet G, Regan DG, Whyte P, Brotherton JM, Richmond P, McCaffrey K, Garland SM, Leask J, Kang M, Braunack-Mayer A, Kaldor J, McGeechan K.

BMC Public Health. 2015 Sep 15;15:896. doi: 10.1186/s12889-015-2168-5.

11.

Illicit and injecting drug use among Indigenous young people in urban, regional and remote Australia.

Bryant J, Ward J, Wand H, Byron K, Bamblett A, Waples-Crowe P, Betts S, Coburn T, Delaney-Thiele D, Worth H, Kaldor J, Pitts M.

Drug Alcohol Rev. 2015 Sep 15. doi: 10.1111/dar.12320. [Epub ahead of print]

PMID:
26369549
12.

Direct real-time PCR-based detection of Neisseria gonorrhoeae 23S rRNA mutations associated with azithromycin resistance.

Trembizki E, Buckley C, Donovan B, Chen M, Guy R, Kaldor J, Lahra MM, Regan DG, Smith H, Ward J, Whiley DM.

J Antimicrob Chemother. 2015 Dec;70(12):3244-9. doi: 10.1093/jac/dkv274. Epub 2015 Sep 3.

PMID:
26338048
13.

A sexual health quality improvement program (SHIMMER) triples chlamydia and gonorrhoea testing rates among young people attending Aboriginal primary health care services in Australia.

Graham S, Guy RJ, Wand HC, Kaldor JM, Donovan B, Knox J, McCowen D, Bullen P, Booker J, O'Brien C, Garrett K, Ward JS.

BMC Infect Dis. 2015 Sep 2;15:370. doi: 10.1186/s12879-015-1107-5.

14.

High HIV Prevalence and Associated Risk Factors Among Female Sexual Partners of Male Injection Drug Users (MWID) in Ho Chi Minh City, Vietnam.

Nadol P, Tran H, Hammett T, Phan S, Nguyen D, Kaldor J, Law M.

AIDS Behav. 2015 Aug 14. [Epub ahead of print]

PMID:
26271814
15.

Methods of a national survey of young Aboriginal and Torres Strait Islander people regarding sexually transmissible infections and bloodborne viruses.

Ward J, Bryant J, Wand H, Kaldor J, Delaney-Thiele D, Worth H, Betts S, Waples-Crowe P, Cairnduff S, Coburn T, Donovan B, Pitts M.

Aust N Z J Public Health. 2015 Aug 10. doi: 10.1111/1753-6405.12427. [Epub ahead of print]

PMID:
26259735
16.

Attendance patterns and chlamydia and gonorrhoea testing among young people in Aboriginal primary health centres in New South Wales, Australia.

Graham S, Wand HC, Ward JS, Knox J, McCowen D, Bullen P, Booker J, O'Brien C, Garrett K, Donovan B, Kaldor J, Guy RJ.

Sex Health. 2015 Jul 27. doi: 10.1071/SH15007. [Epub ahead of print]

PMID:
26210444
17.

HIV prevalence is strongly associated with geographical variations in male circumcision and foreskin cutting in Papua New Guinea: an ecological study.

MacLaren DJ, McBride WJ, Kelly GC, Muller R, Tommbe R, Kaldor JM, Vallely AJ.

Sex Transm Infect. 2015 Nov;91(7):502-5. doi: 10.1136/sextrans-2014-051970. Epub 2015 Jun 30.

18.

Injecting risk behaviours following treatment for hepatitis C virus infection among people who inject drugs: The Australian Trial in Acute Hepatitis C.

Alavi M, Spelman T, Matthews GV, Haber PS, Day C, van Beek I, Walsh N, Yeung B, Bruneau J, Petoumenos K, Dolan K, Kaldor JM, Dore GJ, Hellard M, Grebely J; ATAHC Study Group.

Int J Drug Policy. 2015 Oct;26(10):976-83. doi: 10.1016/j.drugpo.2015.05.003. Epub 2015 May 21.

PMID:
26115881
19.

Dual Intervention to Increase Chlamydia Retesting: A Randomized Controlled Trial in Three Populations.

Smith KS, Hocking JS, Chen MY, Fairley CK, McNulty AM, Read P, Bradshaw CS, Tabrizi SN, Wand H, Saville M, Rawlinson W, Garland SM, Donovan B, Kaldor JM, Guy RJ.

Am J Prev Med. 2015 Jul;49(1):1-11. doi: 10.1016/j.amepre.2015.01.014.

PMID:
26094224
20.

Prevalence of scabies and impetigo worldwide: a systematic review.

Romani L, Steer AC, Whitfeld MJ, Kaldor JM.

Lancet Infect Dis. 2015 Aug;15(8):960-7. doi: 10.1016/S1473-3099(15)00132-2. Epub 2015 Jun 15. Review.

PMID:
26088526
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk